205 related articles for article (PubMed ID: 31748740)
1. Study of the antitumour effects and the modulation of immune response by histamine in breast cancer.
Nicoud MB; Sterle HA; Massari NA; Táquez Delgado MA; Formoso K; Herrero Ducloux MV; Martinel Lamas D; Cremaschi GA; Medina VA
Br J Cancer; 2020 Feb; 122(3):348-360. PubMed ID: 31748740
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of histamine H₄ receptor agonists in triple-negative human breast cancer experimental model.
Martinel Lamas DJ; Croci M; Carabajal E; Crescenti EJ; Sambuco L; Massari NA; Bergoc RM; Rivera ES; Medina VA
Br J Pharmacol; 2013 Sep; 170(1):188-99. PubMed ID: 23425150
[TBL] [Abstract][Full Text] [Related]
3. Histamine therapeutic efficacy in metastatic melanoma: Role of histamine H4 receptor agonists and opportunity for combination with radiation.
Massari NA; Nicoud MB; Sambuco L; Cricco GP; Martinel Lamas DJ; Herrero Ducloux MV; Blanco H; Rivera ES; Medina VA
Oncotarget; 2017 Apr; 8(16):26471-26491. PubMed ID: 28460440
[TBL] [Abstract][Full Text] [Related]
4. Histamine H4 Receptor Agonism Induces Antitumor Effects in Human T-Cell Lymphoma.
Clauzure M; Táquez Delgado MA; Phillip JM; Revuelta MV; Cerchietti L; Medina VA
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163302
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory role of histamine H4 receptor in breast cancer.
Sterle HA; Nicoud MB; Massari NA; Táquez Delgado MA; Herrero Ducloux MV; Cremaschi GA; Medina VA
Br J Cancer; 2019 Jan; 120(1):128-138. PubMed ID: 29988113
[TBL] [Abstract][Full Text] [Related]
6. Role of histamine H4 receptor ligands in bleomycin-induced pulmonary fibrosis.
Lucarini L; Pini A; Rosa AC; Lanzi C; Durante M; Chazot PL; Krief S; Schreeb A; Stark H; Masini E
Pharmacol Res; 2016 Sep; 111():740-748. PubMed ID: 27475884
[TBL] [Abstract][Full Text] [Related]
7. Impact of histamine H4 receptor deficiency on the modulation of T cells in a murine breast cancer model.
Nicoud MB; Táquez Delgado MA; Sarasola MP; Vidal A; Speisky D; Cremaschi GA; Sterle HA; Medina VA
Cancer Immunol Immunother; 2021 Jan; 70(1):233-244. PubMed ID: 32700092
[TBL] [Abstract][Full Text] [Related]
8. Histamine H4 receptor agonists induce epithelial-mesenchymal transition events and enhance mammosphere formation via Src and TGF-β signaling in breast cancer cells.
Galarza TE; Táquez Delgado MA; Mohamad NA; Martín GA; Cricco GP
Biochem Pharmacol; 2020 Oct; 180():114177. PubMed ID: 32721509
[TBL] [Abstract][Full Text] [Related]
9. The role of histamine in human mammary carcinogenesis: H3 and H4 receptors as potential therapeutic targets for breast cancer treatment.
Medina V; Croci M; Crescenti E; Mohamad N; Sanchez-Jiménez F; Massari N; Nuñez M; Cricco G; Martin G; Bergoc R; Rivera E
Cancer Biol Ther; 2008 Jan; 7(1):28-35. PubMed ID: 17932461
[TBL] [Abstract][Full Text] [Related]
10. Histamine induces proliferation in keratinocytes from patients with atopic dermatitis through the histamine 4 receptor.
Glatzer F; Gschwandtner M; Ehling S; Rossbach K; Janik K; Klos A; Bäumer W; Kietzmann M; Werfel T; Gutzmer R
J Allergy Clin Immunol; 2013 Dec; 132(6):1358-67. PubMed ID: 23932072
[TBL] [Abstract][Full Text] [Related]
11. Histamine H4 Receptor Expression in Triple-negative Breast Cancer: An Exploratory Study.
Speisky D; Táquez Delgado MA; Iotti A; Nicoud MB; Ospital IA; Vigovich F; Dezanzo P; Ernst G; Uriburu JL; Medina VA
J Histochem Cytochem; 2022 Apr; 70(4):311-322. PubMed ID: 35227109
[TBL] [Abstract][Full Text] [Related]
12. Histamine drives severity of innate inflammation via histamine 4 receptor in murine experimental colitis.
Wechsler JB; Szabo A; Hsu CL; Krier-Burris RA; Schroeder HA; Wang MY; Carter RG; Velez TE; Aguiniga LM; Brown JB; Miller ML; Wershil BK; Barrett TA; Bryce PJ
Mucosal Immunol; 2018 May; 11(3):861-870. PubMed ID: 29363669
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of LINS01 histamine H
Ospital IA; Táquez Delgado MA; Nicoud MB; Corrêa MF; Borges Fernandes GA; Andrade IW; Lauretta P; Martínez Vivot R; Comba MB; Zanardi MM; Speisky D; Uriburu JL; Fernandes JPS; Medina VA
Biomed Pharmacother; 2024 May; 174():116527. PubMed ID: 38579399
[TBL] [Abstract][Full Text] [Related]
14. Histamine H4 receptor: insights into a potential therapeutic target in breast cancer.
Martinel Lamas DJ; Rivera ES; Medina VA
Front Biosci (Schol Ed); 2015 Jun; 7(1):1-9. PubMed ID: 25961682
[TBL] [Abstract][Full Text] [Related]
15. Allergic inflammation is augmented via histamine H4 receptor activation: The role of natural killer cells in vitro and in vivo.
Ehling S; Roßbach K; Dunston SM; Stark H; Bäumer W
J Dermatol Sci; 2016 Aug; 83(2):106-15. PubMed ID: 27155791
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of the histamine H4 receptor reduces LPS-induced TNF production in vivo.
Cowden JM; Yu F; Challapalli M; Huang JF; Kim S; Fung-Leung WP; Ma JY; Riley JP; Zhang M; Dunford PJ; Thurmond RL
Inflamm Res; 2013 Jun; 62(6):599-607. PubMed ID: 23532396
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinoma.
Francis H; DeMorrow S; Venter J; Onori P; White M; Gaudio E; Francis T; Greene JF; Tran S; Meininger CJ; Alpini G
Gut; 2012 May; 61(5):753-64. PubMed ID: 21873469
[TBL] [Abstract][Full Text] [Related]
18. 2,4-Diaminopyrimidines as dual ligands at the histamine H1 and H4 receptor-H1/H4-receptor selectivity.
Hammer SG; Gobleder S; Naporra F; Wittmann HJ; Elz S; Heinrich MR; Strasser A
Bioorg Med Chem Lett; 2016 Jan; 26(2):292-300. PubMed ID: 26718844
[TBL] [Abstract][Full Text] [Related]
19. Histamine H4 receptor antagonists are superior to traditional antihistamines in the attenuation of experimental pruritus.
Dunford PJ; Williams KN; Desai PJ; Karlsson L; McQueen D; Thurmond RL
J Allergy Clin Immunol; 2007 Jan; 119(1):176-83. PubMed ID: 17208599
[TBL] [Abstract][Full Text] [Related]
20. Activation of ERK/CREB pathway in noradrenergic neurons contributes to hypernociceptive phenotype in H4 receptor knockout mice after nerve injury.
Sanna MD; Mello T; Masini E; Galeotti N
Neuropharmacology; 2018 Jan; 128():340-350. PubMed ID: 29107625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
